Keurig Dr Pepper Inc.

---

source: coverage-next-full ticker: KDP step: 01 title: Business Model & Value Chain retrieved: 2026-05-28

Step 01 — Business Model & Value Chain

Key Findings

• KDP is a brand-IP-led beverage operator with full-stack DSD distribution in North America, generating ~$16.6B FY2025 revenue across three segments (US Refreshment Beverages ~63%, US Coffee ~27%, International ~10%) [S1][S2].
• The economic engine is owned and licensed brand IP (Dr Pepper, Snapple, Canada Dry, 7UP, Mott's, Keurig, GHOST, Bloom) monetized through a proprietary US direct-store-delivery (DSD) network — one of three large US beverage DSD networks alongside Coca-Cola and PepsiCo bottlers [S3]. This DSD network is a structural moat: it converts brand demand into retail availability without intermediary friction.
• Coffee operates a razor + blade model at scale: ~40M Keurig brewers seeded in US homes [S4] generate recurring K-Cup pod revenue. The hardware-pod attach economics resemble a consumables business with installed-base inertia.
• Post-JDE close (April 1, 2026), the entity becomes a global coffee + North American beverages combo with explicit intent to spin into two separately listed companies after integration [S5]. The value-chain map in this step describes the pre-split combined structure.

Implications for Thesis and Valuation

• Revenue durability is grounded in (a) Dr Pepper trademark loyalty (~80+ years), (b) Keurig brewer installed-base lock-in, (c) DSD network breadth. None require ongoing innovation to maintain baseline cash flow.
• Growth comes from three layers: (1) Dr Pepper share gains in US CSDs, (2) energy-drinks expansion via GHOST + Bloom, (3) post-JDE global coffee scale. Each has distinct unit economics that will be modeled separately downstream.
• Valuation must reflect the announced two-company separation: long-term steady-state value is best assessed as Refreshment Beverages Co. (stable mid-single growth, dividend payer) + Global Coffee Co. (mid-single-digit organic growth, lower-margin, more international FX exposure) rather than as a single combined entity.

Objective

Map KDP's business model, value-chain layers, customer economics, and revenue model. Establish the layered structure that Steps 02 (industry), 03 (revenue architecture), and 10 (moat) will refine.

Narrative Analysis

KDP sells branded beverages through retail (grocery, mass, club, c-store, dollar) and foodservice channels in North America, augmented by an at-home single-serve coffee ecosystem and — after April 2026 — a global packaged-coffee footprint via JDE Peet's [S1][S5].

Core revenue model — branded beverages segment. KDP owns or licenses brand IP (~125 brand families), produces concentrate/syrup at internal plants, packages/bottles at company-owned and contract-bottler facilities, and distributes via its proprietary DSD network and warehouse channels. The DSD model lets KDP control shelf placement, refresh frequency, and promotional execution at the store level — a meaningful operating moat in mature retail [S3]. Volume is sold to retailers at wholesale; final consumer purchase is made at retail.

Razor + blade — coffee segment. Keurig brewers (made at low margin, sometimes intentionally subsidized) seed the installed base; K-Cup pod sales (high margin, recurring, ~6-month consumption cycle) generate the durable cash flow. KDP estimates ~40M active brewers in US homes [S4]. Licensed brand partners (Starbucks, Dunkin', etc.) pay for K-Cup format access, providing high-margin license revenue without inventory exposure.

Energy drinks — emerging layer. GHOST (acquired 60% Jan 2025, remaining 40% planned 2028) plus Bloom (partnership) give KDP a position in the fastest-growing US beverage subcategory. Unit economics in energy are attractive (high gross margin, premium price points), and KDP's DSD network is the lever — GHOST struggled with distribution depth pre-acquisition [S6].

International — Mexico-led. Peñafiel is the #2 carbonated mineral water in Mexico; Squirt is a top brand. Canada operations distribute Dr Pepper/Snapple portfolio. Both are mature, GDP-paced markets but offer FX-translation exposure.

Post-JDE addition — global packaged coffee. Jacobs, Douwe Egberts, Peet's Coffee, L'OR, Tassimo, Senseo, Old Town White Coffee — predominantly European and Asian retail and foodservice channels. JDE Peet's was the global #2 packaged coffee company pre-acquisition (behind Nestlé). Brings ~€8B+ revenue, ~22%+ EBITDA margin, and distribution depth in 100+ countries [S5].

Customer economics. End customer (consumer) buys at retail; KDP earns the spread between input/manufacturing/distribution cost and wholesale price to retailer. The "stickiest" customer relationships are (a) Keurig brewer households (hardware lock-in), (b) Dr Pepper habit consumers (trademark loyalty), (c) commercial coffee accounts via JDE in Europe. Retailer relationships are concentrated — Walmart, Kroger, Costco, Target are top US accounts; major grocery chains are top international accounts.

Evidence and Sources

Value-Chain Layer Map

Layer	What KDP does	Owned vs. partnered	Why it matters
Brand IP	Owns or licenses ~125 brand families	Owned (Dr Pepper, Snapple, Mott's, etc.) + licensed (Crush, Sunkist regional, Starbucks K-Cup, etc.)	Source of pricing power; ROIC depends on durable trademark equity
Concentrate/syrup mfg	Internal plants	Owned	Margin capture at the chemistry step
Bottling/packaging	Mix of owned (Pepsi-style) + contract bottlers	Mostly owned in US	Capital intensity moderate; controls cost + quality
DSD distribution	Proprietary US network	Owned	Structural moat; one of 3 scaled US beverage DSDs
Warehouse/retail logistics	Large-format retail (Walmart/Costco) via warehouse channel	Owned + 3PL	Lower-cost serve for large retailers
Coffee hardware	Keurig brewer design + contract mfg	Designed in-house, contract-built	Razor in the razor+blade
K-Cup pods	KDP-owned formats + licensed partner brands	Owned format IP + partner brand licensing	Recurring high-margin blade
Energy drinks	GHOST owned, Bloom partner	Mix	Growth optionality at attractive unit margins
International beverages	Mexico + Canada owned operations	Owned	FX-exposed but stable cash; growing
Global packaged coffee (post-Apr 2026)	JDE Peet's portfolio	Owned (96.22%)	Step-change scale; intent to spin

Assumption Register Updates

(No new numeric assumptions in this step; structure-only. Future quantification of brand-level revenue mix will be added in Step 03.)

Tables and Calculations

Segment Revenue Split (FY2025, USD M, approximate)

Segment	FY2025 Revenue	% of Total	Operating Margin (approx)
US Refreshment Beverages	~10,400	~63%	~28-30% (segment basis)
US Coffee	~4,500	~27%	~28% (lower than RB due to commodity passthrough)
International	~1,700	~10%	~20-22%
Total	16,603	100%	n/a (consolidated incl. corporate ~21.5% reported)

Segment-level operating margins are approximate from public reconciliation tables; precise breakdown will be cross-checked in Step 03.

Revenue Model Type by Segment

Segment	Revenue Model	Recurrence	Pricing Mechanism
US Refreshment Beverages	Wholesale brand sale to retail	Habitual consumption	List + promotional + trade-spend
US Coffee — K-Cup pods	Recurring consumables (razor+blade blade)	Very high (installed-base inertia)	Annual list + tiered pack pricing
US Coffee — Brewers	Hardware one-shot	Replacement cycle ~3-5 years	Premium tiered SKU
International	Wholesale brand sale	Habitual + commercial	Localized list pricing
Global Coffee (post-Apr 2026)	Wholesale + foodservice + DTC	Habitual + commercial recurring	Mix of branded + private-label tiers

Open Questions and Data Gaps

• Exact brand-level revenue (e.g., Dr Pepper alone vs. Snapple vs. Canada Dry within US RB) is not disclosed; Step 03 will use Circana category share + IR commentary to triangulate
• K-Cup attach rate per brewer (annual pods/brewer) not disclosed in detail; can be estimated from segment volume data
• JDE Peet's standalone P&L only available from JDE's pre-deal disclosures (Euronext filings through April 2026); ongoing breakdown will be at KDP's segment-reporting discretion post-Q2 2026

Next-Step Dependencies

Step 02 will use this value-chain layer map to assess where competitive friction is highest (concentrate mfg, DSD, brand IP) and structure the Porter five-forces analysis accordingly.

Source Index

Tag	Document / URL	Section	Date	Notes
[S1]	KDP 10-K FY2025	https://www.sec.gov/Archives/edgar/data/0001418135/000141813526000016/kdp-20251231.htm	Feb 2026	Business overview
[S2]	KDP XBRL summary	KDP_financials/xbrl/xbrl_summary.md	2026-05-28	FY2025 segment revenue
[S3]	KDP industry analysis	KDP_financials/industry/competitive_landscape.md	2026-05-28	DSD network discussion
[S4]	KDP Q1 2024 disclosures (40M Keurig brewers in US)	KDP investor presentation Q1 2024 + Statista 2025	2025	Single-serve coffee installed base
[S5]	KDP 8-K April 1 2026 (JDE close)	https://news.keurigdrpepper.com/2026-04-01	Apr 2026	JDE Peet's acquisition close + Rafael Oliveira
[S6]	GHOST acquisition press release	https://news.keurigdrpepper.com/2024-10-24-Keurig-Dr-Pepper-to-Acquire-Disruptive-Energy-Drink-Business-GHOST	Oct 2024	$990M for 60%, plus 40% in 2028

---

source: coverage-next-full ticker: KDP step: 04 title: Financial Quality & Adversarial Sweep retrieved: 2026-05-28

Step 04 — Financial Quality & Adversarial Sweep

Key Findings

• KDP financial reporting is mature, multi-year-consistent, GAAP-to-adjusted disciplined. Adjustments are clearly itemized in earnings release reconciliation tables. No restatements, no SEC enforcement actions on accounting [S1].
• The most material non-cash adjustment of the past 5 years was the FY2024 Q4 ~$600M brand impairment on Snapple/Bai, which compressed GAAP operating margin from ~21% (FY2023) to ~17% (FY2024) [S2]. This was not a cash event but is a warning sign on legacy non-core brand health.
• Adversarial sweep: no active class-action securities litigation, no SEC enforcement, no major short-seller report on KDP. The 2018 reverse merger with JAB's Keurig Green Mountain was scrutinized for valuation at the time but no fraud allegations emerged. JAB's controlled-company status (until May 2025) was a disclosed governance feature, not a violation.
• Goodwill and indefinite-lived intangibles (~$44B combined, ~80% of pre-JDE assets) is a structural valuation risk — impairment events could be triggered by a sustained downturn in any major brand. The Snapple/Bai impairment is precedent.

Implications for Thesis and Valuation

• Earnings quality is acceptable; analysts can trust the adjusted-EPS framework for forward modeling.
• Embed an impairment-risk scenario in valuation: a downside case in which Bai or another legacy brand triggers another non-cash charge (~$200-500M range). This is GAAP-only and does not affect cash valuation but could pressure reported margin optics.
• Goodwill/intangibles weighting (post-JDE will reach ~$80B combined intangibles + goodwill on a ~$100B+ asset base) means ROIC analysis must be done both on reported (low) and tangible/cash basis (much higher) — see Step 09.

Objective

Assess quality of reported financials, distinguish recurring vs. one-time items, surface legal/regulatory/short-seller risks via adversarial research.

Narrative Analysis

KDP's financial reporting framework follows standard CPG conventions. Annual 10-K and quarterly 10-Q filings include GAAP financials plus reconciliations to "adjusted" measures (Adjusted EBITDA, Adjusted Operating Income, Adjusted EPS) that strip out items management deems non-recurring or non-operational. The earnings release reconciliation tables are typically transparent — labeling impairment charges, restructuring, M&A-related expenses, and tax effects line by line [S1].

Key non-cash items in the FY2020-FY2025 window:

• FY2024 Q4: ~$600M non-cash brand impairment, primarily on Snapple and Bai trademark carrying values [S2]. Drove GAAP operating income down from $3.19B (FY2023) to $2.59B (FY2024), while adjusted operating income held closer to flat. This reflected post-acquisition fair-value reassessment as these brands underperformed against the 2018-2020 carrying-value assumptions.
• Annual SBC: ~$100-120M/year (~0.6-0.8% of revenue) — modest by tech standards, slightly above traditional CPG peers but within normal range [S3].
• Restructuring charges: episodic ~$30-80M/year tied to supply-chain optimization and post-merger integration.

Cash flow quality. Operating cash flow has been volatile: $2.87B (FY2022) → $1.33B (FY2023) → $2.22B (FY2024) → $1.99B (FY2025) [S3]. The FY2023 dip reflected working capital tightening (inventory build for category re-stock, tariff prep), not earnings quality issues. Conversion of net income to OCF: in normal years 1.2-1.4x; in FY2023 ~0.6x (the working-capital year); rebound thereafter. FCF is consistent at $1.5-2.5B/year ex-FY2023.

Tax rate. FY2025 GAAP effective tax rate ~29.7%; multi-year average ~25-28% (reflecting state tax + international mix). No aggressive tax planning that would invite IRS challenge.

Adversarial sweep results:

Risk Vector	Finding	Disposition
SEC enforcement	None active	Clear
Securities class actions	No active material cases	Clear
Major short-seller reports	No (KDP has not been a public short target)	Clear
Auditor changes	Deloitte continuous since merger; no qualified opinions	Clear
Restatements	None in 8-year reporting history	Clear
Accounting concerns	Conservative reserves; intangibles tested annually	Clear (but intangibles structural risk noted)
Whistleblower / 8-K disclosures	None	Clear
Regulatory (FDA/FTC)	Routine label compliance items; no consent decrees on advertising or sweeteners	Clear
Antitrust (M&A reviews)	GHOST acquisition cleared FTC; JDE Peet's cleared EU/FTC	Clear
Tax disputes	None disclosed material	Clear
ESG controversies	Standard CPG (sugar advocacy, plastic packaging) — not litigation-grade	Monitoring

Aggressive accounting watch items: None identified. KDP has not flagged any change in revenue recognition policy, has not relied on bill-and-hold or channel-stuffing patterns, and segments are reported consistently across periods.

Legacy issues from pre-merger entities: The original Keurig Green Mountain in the pre-JAB era (early 2010s) faced consumer class actions on K-Cup pod compatibility (now resolved). The 2018 merger structure (reverse Morris Trust-style with JAB cash injection) drew Wall Street debate at the time but was deemed legitimate. No active legacy litigation impacts current cash flow.

Evidence and Sources

GAAP vs. Adjusted Operating Income Walk (FY2024 → FY2025)

Item	FY2024 ($M)	FY2025 ($M)
GAAP Operating Income	2,591	3,575
Brand impairment (Snapple/Bai) — added back	600	0
M&A-related costs — added back	50	120 (GHOST integration + JDE deal)
Restructuring — added back	70	60
Other one-time items	(10)	(40)
Adjusted Operating Income	3,301	3,715
Adjusted Op Margin	21.5%	22.4%

Reconciliation figures are illustrative; precise figures vary by quarter and are disclosed in earnings release reconciliation tables.

Assumption Register Updates

A9 (FY2024 op-income drag from impairments ~$600M) and A10 (legacy brand impairment risk continuing) added.

Tables and Calculations

Earnings Quality Indicators

Indicator	FY2023	FY2024	FY2025	Disposition
Net income / OCF ratio	1.64x	0.65x	1.04x	Normal range
OCF / CapEx (coverage)	3.13x	3.94x	4.10x	Strong
SBC / Net income	5.3%	6.8%	4.7%	Modest
Working capital days	~50	~58	~52	Normal seasonal
Goodwill / Equity	0.79x	0.83x	0.79x	High (CPG-typical for M&A-led)
Effective tax rate	25.0%	22.0%*	29.7%	Normal range; FY2024 had impairment tax shield

FY2024 effective tax rate distorted by impairment-related deferred tax adjustment.

Open Questions and Data Gaps

• Bai brand carrying value post-FY2024 impairment: trajectory unclear; could face further write-down if consumer trends remain weak
• Post-JDE integration: how much of the $4.5B Apollo/KKR convertible preferred coupon will hit GAAP earnings vs. equity (depends on accounting classification of the convertible instrument)
• JDE Peet's pre-existing legal contingencies: not yet fully disclosed in KDP 10-Q

Next-Step Dependencies

Step 09 (Returns on Capital) will use the goodwill/intangibles weighting analysis here to compute both reported and tangible ROIC. Step 11 (External Risk Overlay) will revisit regulatory exposures.

Source Index

Tag	Document / URL	Section	Date	Notes
[S1]	KDP 10-K FY2025 financial statements + notes	https://www.sec.gov/Archives/edgar/data/0001418135/000141813526000016/kdp-20251231.htm	Feb 2026	GAAP reporting framework
[S2]	KDP Q4 2024 earnings release (impairment disclosure)	https://news.keurigdrpepper.com/2025-02-25	Feb 2025	$600M brand impairment Snapple/Bai
[S3]	KDP XBRL summary	KDP_financials/xbrl/xbrl_summary.md	2026-05-28	OCF, SBC, EPS multi-year

---

source: coverage-next-full ticker: KDP step: 12 title: Catalysts / Analyst Debate (Bull vs. Bear) retrieved: 2026-05-28

Step 12 — Catalysts / Analyst Debate

Note: This step adopts the /full-research-gpt Step 12 analyst-debate analytical framework but, since earnings-call transcripts are intentionally not loaded in the coverage-next-full path, the bull/bear positions are reconstructed from sell-side notes, KDP press releases, prepared-remarks summaries embedded in 8-Ks, and consensus aggregators rather than direct CEO/CFO color. This means nuance on forward guidance from management Q&A is not captured here.

Key Findings

• The 12-month KDP investment debate is dominated by three intersecting questions: (1) Does the JDE Peet's integration deliver promised cost + revenue synergies on schedule, (2) Does the planned split into Refreshment Beverages Co. + Global Coffee Co. create sum-of-parts value, and (3) Can Dr Pepper continue gaining US CSD share at 50-100bps annually [S1][S2].
• Sell-side consensus is constructive but cautious: Buy/Outperform = 10, Hold = 7, Sell = 0; average 12-month price target ~$35.47 vs. ~$29.30 spot = ~21% implied upside [S3]. Bulls argue the leverage spike is transitory; bears point to integration risk and the GLP-1 secular drag.
• The biggest near-term catalyst (positive) is the Q3 2026 earnings report — first full quarter of post-JDE consolidated results — which will set the integration credibility baseline.
• The biggest near-term risk (negative) is a guidance trim if synergy capture lags, which would cement the bear thesis.

Implications for Thesis and Valuation

• The base-case 12-month TSR scenario is ~10-15% (upside to ~$33-34 + 3.2% dividend) reflecting modest deleveraging credit and a small split-optionality bump.
• The bull-case 24-month TSR scenario is +40-50% if the split clears antitrust + JDE synergies deliver $300M+ annualized.
• The bear-case 12-month TSR scenario is -15-20% if Q3 2026 disappoints or JDE leverage burdens force dividend signaling concerns.

Objective

Reconstruct the canonical bull/bear analyst debate from filings + consensus + recent news; assess sentiment; identify the next 4-6 catalysts (positive and negative) that will resolve key debate questions; close with a 3+3 Bull Case / Bear Case bullet block that feeds /complete-coverage Step 15 and the public /stocks page.

Narrative Analysis

The Three Active Debates

Debate #1 — JDE Peet's Integration: Value Creation vs. Distraction

The dominant question. Bulls (BofA, Goldman, Jefferies in late-Feb/March 2026 notes) emphasize that KDP gains global coffee scale that closes the gap with Nestlé, that ~$200-400M cost synergies are achievable given overlapping G&A and procurement, and that the deal is structurally accretive to long-term ROIC if the split unlocks separate-multiple value. Bears (UBS, Wells Fargo, Truist) argue the deal is strategically scattershot — KDP is already in coffee via Keurig — and that the timing was opportunistic at JDE's distressed multiple rather than strategic. They cite the rapid leverage spike to 4.5x as a constraint on capital return, the integration execution risk for a company doing two transformational deals in 18 months (GHOST + JDE), and the absence of formal synergy targets at the closing [S4].

The neutral read: the deal is defensible at the price paid (12-13x estimated trailing EBITDA, reasonable for a category #2 with stable margins) but executes on uncertain ground. Final grade requires 2027-2028 results.

Debate #2 — The Split Into Two Companies

KDP's announced intent to separate into Refreshment Beverages Co. (US CSDs + DSD-distributed brands + energy) and Global Coffee Co. (Keurig + JDE Peet's combined) is a sum-of-parts unlock thesis. Bulls model: Refreshment Beverages Co. at 16-18x EBITDA (similar to KO/PEP standalone CSD optionality), Global Coffee Co. at 12-14x EBITDA (Nestlé Health Science + Lavazza comps). Combined SOP = ~$33-37/share, vs. current ~$29-30. Implied upside ~15-25% if split executes by 2028.

Bears point to (a) execution risk — no formal timetable; (b) potential antitrust modifications to the JDE-acquired assets; (c) the dis-synergy of separating shared services, IT, procurement, marketing infrastructure. Wells Fargo's Feb 2026 note estimates ~$150-200M one-time separation costs and ~$50-75M annual dis-synergies post-split [S5].

The neutral read: the option value is real and underpriced, but it is option value — investors must accept multi-year holding and uncertain timing.

Debate #3 — Dr Pepper Share Gain Durability

Dr Pepper has reportedly become the #2 CSD trademark in the US (overtaking Pepsi in some Nielsen/Circana cuts) by mid-2025, with reported share gains of 50-100bps annually since 2022 [S6]. Bulls argue this is structural — the brand has a unique flavor profile, marketing has been highly effective ("Fansville" campaign), and the trade has rewarded Dr Pepper with shelf gains. Bears argue this is mean-reversion-prone — Pepsi has structurally responded with category-management investments and pricing flexibility — and that share gains decelerate once the trademark reaches saturation in heavy-CSD geographies.

The neutral read: continued share gain at 50-100bps annually is achievable through 2026-2027 but the gain rate decelerates as the brand approaches structural ceiling (likely 12-13% US CSD trademark share).

Consensus Snapshot (as of late May 2026)

Metric	Value	Source
Coverage	17 analysts	[S3]
Buy / Outperform	10	[S3]
Hold	7	[S3]
Sell	0	[S3]
12-month avg PT	$35.47	[S3]
12-month PT range	$24-42	[S3]
Current price (May 2026)	~$29.30	[S3]
Implied upside	~21% to mean PT	[S3]
FY2026E adj EPS	~$2.05	[S3]
FY2027E adj EPS	~$2.55	[S3]
FY2027E revenue (combined)	~$40.9B	[S3]
Current fwd P/E	~14.3x FY2026E	Derived

Catalyst Calendar (next 18 months)

Date	Catalyst	Direction	Why It Matters
Late July 2026	Q2 2026 earnings (last standalone-KDP quarter ex JDE)	Neutral	Bridge to pre-/post-deal comparison; integration prep update
Late October 2026	Q3 2026 earnings (first full post-JDE consolidated quarter)	High-stakes	Synergy run-rate, organic-growth quality, leverage trajectory all crystallize
Late Feb 2027	FY 2026 + Q4 2026 release; FY 2027 guidance	High	First combined-entity full-year framework
Q1-Q2 2027	Formal synergy target disclosure (expected timing)	High	Markets need to peg synergy capture to ROIC
Mid-2027	Antitrust / regulatory milestone updates on the split	Medium	Removes split-timing tail risk
Late 2027	Net leverage progress to ~4.0x	Medium	Validates deleveraging glide path
2028	Split timeline announcement; possible Form 10 filings	High	Unlocks SOP optionality

Recent News Flow (last 90 days)

• April 23, 2026: Q1 2026 earnings — reaffirmed FY 2026 guidance of low-DD net sales + adj EPS growth; commentary positive on Dr Pepper share, US Coffee stable, GHOST contributing 6+ pp [S7]
• April 1, 2026: JDE Peet's deal closed — leadership announcements (Rafael Oliveira to lead Global Coffee Co.; Tim Cofer to lead Refreshment Beverages Co.) [S2]
• March 10, 2026: Equity offering completed — 130M shares at $26.50 = $3.45B [S8]
• February 23, 2026: Financing transactions detailed in 8-K — $4.5B convertible preferred (Apollo/KKR), $9B new term debt [S1]
• February 24, 2026: Q4 2025 earnings release — initial FY 2026 guide given; reaffirmed at Q1 2026 [S9]

Sell-Side Sentiment Detail

• Bulls (avg PT ~$38-42): BofA ($42), Goldman ($40), Jefferies ($38), Morgan Stanley ($39). Thesis: JDE creates global coffee #2; split unlocks SOP; Dr Pepper compounds share; energy via GHOST scales; deleveraging credit by end-2027.
• Holds (avg PT ~$32-35): UBS ($32), Wells Fargo ($34), Truist ($33), Citi ($35). Thesis: Deal-execution uncertainty + leverage drag + GLP-1 long-term overhang offset operational momentum.
• No active Sell ratings as of May 2026.

Variant Analyst Views (Worth Highlighting)

• Goldman flags KDP as a "core long-duration compounder" trading at a discount to KO/PEP not justified by 2028 normalized economics [S3].
• UBS flags the convertible preferred as the most under-discussed risk — sponsor dilution at conversion could meaningfully reset share count [S3].
• Wells Fargo estimates ~$150-200M one-time separation costs and ~$50-75M annual dis-synergies on the split [S5].

Assumption Register Updates

• A24: 12-month PT (consensus mean): $35.47 — Type: Fact
• A25: Spread to bull PT: ~$42 = ~43% upside — Type: Fact
• A26: Spread to bear PT: ~$24 = ~18% downside — Type: Fact
• A27: Implied probability-weighted 12mo return (consensus-weighted): ~12-15% — Type: Estimate

Tables and Calculations

Bull / Bear / Neutral Probability Weights (filings + consensus derived)

Outcome	Weight	Catalysts
Bull	30%	JDE synergies > $400M; split clears <12mo; Dr Pepper gains 100bps+ annually; deleveraging on schedule
Base	45%	JDE synergies $200-300M; split executes 2028; share gains continue at 50-75bps; gradual deleveraging
Bear	25%	Synergies <$150M; split delayed > 24mo; GLP-1 drag bites Dr Pepper Zero Sugar; leverage stays elevated

24-Month Implied Returns by Scenario

Scenario	EOP Price	TSR (incl div)	Probability	EV
Bull	~$42	+50%	30%	+15.0pp
Base	~$33	+18%	45%	+8.1pp
Bear	~$24	-14%	25%	-3.5pp
Weighted EV				~+19.6%

The 24-month probability-weighted return is materially above the 12-month consensus PT-implied return (~21%) because the split optionality lengthens the realization horizon.

Open Questions and Data Gaps

• Apollo/KKR convertible preferred conversion price — not in public filings; matters for diluted share count
• Formal synergy quantification — KDP has not publicly committed to a $-target
• Split timeline — explicit Form-10 filing date is the key data point still missing
• Q2 2026 print (late July) is the next material data injection

Next-Step Dependencies

Step 13 (/complete-coverage forecast) builds explicit revenue/margin/EPS forecasts using the assumption register above. Step 15 scenarios formalize the 30/45/25 probability weights. Step 16 (Variant) examines what the market is mispricing vs. consensus.

Source Index

Tag	Document / URL	Section	Date	Notes
[S1]	KDP 8-K — JDE financing transactions	$4.5B convertible preferred + $9B term debt	Feb 23, 2026	Cap structure
[S2]	KDP 8-K — JDE close announcement	Leadership + structure	Apr 1, 2026	Closing terms
[S3]	KDP_financials/other/consensus.md	Analyst coverage + PT distribution	May 2026	Aggregator-sourced
[S4]	UBS / Wells Fargo / Truist notes	KDP rating + thesis	Feb-Apr 2026	Hold-rating bear theses
[S5]	Wells Fargo Feb 2026 note	Split cost estimate	Feb 2026	$150-200M one-time + dis-synergies
[S6]	KDP Q4 2025 + Q1 2026 PRs	Dr Pepper share gain commentary	Feb-Apr 2026	#2 CSD trademark
[S7]	KDP Q1 2026 earnings PR	GHOST contribution + segment commentary	Apr 23, 2026	GHOST 6+ pp
[S8]	KDP 8-K equity offering	130M shares at $26.50	Mar 10, 2026	$3.45B equity raise
[S9]	KDP Q4 2025 earnings PR	FY 2026 guidance	Feb 24, 2026	Low-DD growth guide

---

Bull Case — 3 bullets

1. JDE Peet's integration delivers $300M+ run-rate synergies + Refreshment Beverages Co. + Global Coffee Co. split successfully executes by 2028 — sum-of-parts implies ~$33-37/share equity value, ~15-25% upside from current ~$29.30 with the split unlocking previously-discounted coffee economics at coffee-pure-play multiples (Nestlé Health Science / Lavazza comp set).
2. Dr Pepper sustains 50-100bps annual US CSD trademark share gains through 2026-2027 — combined with disciplined pricing (mid-single-digit net realized rev / case via Zero Sugar mix + premiumization), the brand alone could contribute 200-300bps of organic growth, providing a defensible compounder profile even before GHOST/Bloom scaling.
3. GHOST + Bloom scale to $1B+ combined energy revenue by 2028 — KDP's DSD network turns under-distributed cult brands into national distribution; energy/wellness becomes a 10%+ revenue segment with double-digit organic growth, structurally diversifying the portfolio away from CSD GLP-1 risk.

Bear Case — 3 bullets

1. **JDE Peet's integration disappoints — synergies <$150M, split delayed past 2028, or dis-synergies higher than modeled** — leverage stays elevated at >4x net debt/EBITDA through 2027, dividends grow at single-digits not double-digits, and the equity multiple compresses to ~11-12x adj EPS (vs. KO/PEP at ~22-25x).
2. GLP-1 secular demand erosion accelerates beyond mitigation pace — US household penetration of semaglutide/tirzepatide hits 25%+ by 2028 (vs. 12-15% in 2026), driving 1.5-2.0pp annual CSD volume drag that Zero Sugar/Bloom upside can only partially offset; results miss consensus organic growth by 100-200bps annually 2027-2028.
3. Apollo/KKR convertible preferred dilution surprises — sponsors exit at conversion in 2027-2028 adding 7-9% to diluted share count, simultaneously a Mondelez residual stake sell-down pressures price; combined cap-structure overhang produces a 12-month price drag of 10-15% even before fundamental concerns crystallize.